Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2012. Start Trial.
Date Value
December 31, 2025 42.03M
December 31, 2024 38.05M
December 31, 2023 -18.39M
December 31, 2022 -25.24M
December 31, 2021 -19.29M
December 31, 2020 33.43M
December 31, 2019 -2.769M
Date Value
December 31, 2018 -4.007M
December 31, 2017 -14.31M
December 31, 2016 -16.52M
December 31, 2015 -9.752M
December 31, 2014 -3.35M
December 31, 2013 -0.546M
December 31, 2012 -1.776M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Natera, Inc. 215.30M
Caris Life Sciences, Inc. 75.44M
Myriad Genetics, Inc. 1.80M
BioRestorative Therapies, Inc. -10.79M
Exagen, Inc. -13.62M